Incidental findings in UK healthy volunteers screened for a COVID-19 vaccine trial by Hodgson, SH, Iveson, P, Larwood, J, Roche, S, Morrison, H, Cosgrove, C, Galiza, E, Ikram, S, Lemm, N-M, Mehdipour, S, Owens, D, Pacurar, M, Schumacher, M, Shaw, RH, Faust, SN, Heath, PT, Pollard, AJ, Emary, KRW, Pollock, KM, Lazarus, R

Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadth by Pollock, K, Cheeseman, H, McFarlane, L, Day, S, Tolazzi, M, Turner, H, Joypooranachandran, J, Shramko, K, Dispinseri, S, Mundsperger, P, Bontjer, I, Lemm, N-M, Coelho, S, Tanaka, M, Cole, T, Korber, B, Katinger, D, Ward, A, Scarlatti, G, Sanders, R, Sattentau, Q, Shattock, R

An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial by Pollock, KM, Borges, AH, Cheeseman, HM, Rosenkrands, I, Schmidt, KL, Søndergaard, RE, Day, S, Evans, A, McFarlane, LR, Joypooranachandran, J, Amini, F, Skallerup, P, Dohn, RB, Jensen, CG, Olsen, AW, Bang, P, Cole, T, Schronce, J, Lemm, N-M, Kristiansen, MP, Andersen, PL, Dietrich, J, Shattock, RJ, Follmann, F